コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 o received chemotherapy containing high-dose procarbazine.
2 c agents: cyclophosphamide, mitomycin C, and procarbazine.
3 , at best, a few weeks longer than that with procarbazine.
4 treating the parent xenograft D-245 MG with procarbazine.
5 01), ifosfamide (0.42, 0.23-0.79; p=0.0069), procarbazine (0.30, 0.20-0.46; p<0.0001) and cisplatin (
6 ith five cycles of high-dose MTX 3.5 g/m(2), procarbazine 100 mg/m(2)/d, and vincristine 1.4 mg/m(2).
10 ents, risks and benefits of exposure to both procarbazine and subdiaphragmatic radiotherapy should be
12 ; or VAMP/cyclophosphamide, vincristine, and procarbazine) and involved-field radiation therapy deliv
13 eived two cycles of vincristine, prednisone, procarbazine, and doxorubicin or vincristine, prednisone
14 les of methotrexate 2.5 g/m(2), vincristine, procarbazine, and intraventricular methotrexate (12 mg).
15 on as alternating chlorambucil, vinblastine, procarbazine, and prednisolone (ChlVPP) with prednisolon
16 doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone (BEACOPP baseline) or four
17 doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone (BEACOPP) had continuous am
18 doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone (BEACOPPesc) and INRT (supe
19 e, the regimen of chlorambucil, vinblastine, procarbazine, and prednisone (ChlVPP) has been proposed
20 doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone (eBEACOPP) for six cycles.
21 emotherapy was mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) or procarbazine, mec
22 ned to compare mechlorethamine, vincristine, procarbazine, and prednisone (MOPP)/doxorubicin, bleomyc
23 and etoposide/mechlorethamine, vincristine, procarbazine, and prednisone (ProMACE[day 1]-MOPP[day 8]
24 doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone at baseline over ABVD was n
25 e, etoposide, nitrogen mustard, vincristine, procarbazine, and prednisone in similar patient populati
26 , adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) followed by two cycles of
27 doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) has significantly improved
28 , adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in the German Hodgkin Stud
29 doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) on the fertility of male p
30 apy with MOPP (mechlorethamine, vincristine, procarbazine, and prednisone), ABVD (doxorubicin, bleomy
31 doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone), and six cycles of COPP-EB
33 doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone, menstrual activity was str
34 ess the efficacy of rituximab, methotrexate, procarbazine, and vincristine (R-MPV) followed by consol
36 s of induction chemotherapy (rituximab, MTX, procarbazine, and vincristine [R-MPV]) as follows: day 1
37 specially over 10 Gy), alkylating agents and procarbazine, at older ages, were significant risk facto
40 , high-dose methotrexate [MTX], vincristine, procarbazine) followed by a novel consolidation high-dos
41 ation to the stomach >/= 25 Gy and high-dose procarbazine (>/= 5,600 mg/m(2)) had strikingly elevated
43 strate here that giving a GnRH agonist after procarbazine injection also enhances spermatogenesis and
44 lts of this trial showed that treatment with procarbazine, lomustine (also called CCNU), and vincrist
46 y; range 54 to 55 Gy) and nitrosourea-based (procarbazine, lomustine [CCNU], and vincristine [PCV-3 r
48 rapy-carboplatin, vincristine, temozolomide, procarbazine, lomustine, and thioguanine-at age 4.5 year
49 se III clinical trial investigating adjuvant procarbazine, lomustine, and vincristine (PCV) chemother
50 e III study on the addition of six cycles of procarbazine, lomustine, and vincristine (PCV) chemother
51 sted a progression-free survival benefit for procarbazine, lomustine, and vincristine (PCV) chemother
52 tients with AO/AOA were randomly assigned to procarbazine, lomustine, and vincristine (PCV) plus radi
53 our knowledge, the first randomized trial of procarbazine, lomustine, and vincristine (PCV) versus TM
54 51), the addition of neoadjuvant or adjuvant procarbazine, lomustine, and vincristine (PCV; respectiv
56 stic oligodendroglioma patients treated with procarbazine, lomustine, and vincristine chemotherapy.
57 Both temozolomide and the combination of procarbazine, lomustine, and vincristine provide surviva
60 ith those who received radiation < 25 Gy and procarbazine < 5,600 mg/m(2) (Pinteraction < .001).
61 eived radiation to the stomach >/= 25 Gy but procarbazine < 5,600 mg/m(2); however, no procarbazine-r
62 tine, procarbazine, and prednisone (MOPP) or procarbazine, mechlorethamine, and vinblastine (PAVe) in
65 logues or steroids either before exposure to procarbazine or radiation or after irradiation enhances
66 doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone) are maturing with promising re
67 doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone) in children with high-risk HL
68 ine (ABVD) and mechlorethamine, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vi
69 of COPP/ABV (cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, vinbla
70 dacarbazine; cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, vinbla
71 ut procarbazine < 5,600 mg/m(2); however, no procarbazine-related risk was evident with radiation < 2
72 n addition to abdominal radiation, high-dose procarbazine (relative risk, 3.2 [CI, 1.1 to 9.4]) and p
73 tertile HR, 0.42; 95% CI, -0.31 to 0.57) or procarbazine (second tertile HR, 0.48; 95% CI, -0.26 to
75 D-245 MG (PR) xenografts were resistant to procarbazine, temozolomide, N-methyl-N-nitrosourea, and
76 an, prednisone, epidoxorubicin, vincristine, procarbazine, vinblastine, and bleomycin; CEC) in patien
78 clophosphamide, vincristine, prednisone, and procarbazine were added in TG2 (intermediate stages) or
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。